sPRR

By Anonymous (not verified) , 13 November 2025
Disease's type
GDM
Experimental grouping
GDM group (n = 44) and non-GDM group (n = 672)
GPT's summary
This study investigated the association between plasma soluble (pro)renin receptor [s(P)RR] concentrations during early pregnancy and the risk of gestational diabetes mellitus (GDM) in a prospective cohort of 716 pregnant women without preexisting diabetes. Among the participants, 44 (6.1%) developed GDM. Plasma s(P)RR concentrations were divided into quartiles (Q1: <25.8 ng/mL, Q4: >34.2 ng/mL), with GDM prevalence increasing across quartiles: 4.0% in Q1, 2.8% in Q2, 7.2% in Q3, and 10.6% in Q4. Multivariate analysis revealed that women in the highest quartile (Q4) had a 2.90-fold increased risk of developing GDM compared to those in the lowest quartile (Q1) (95% CI: 1.11–7.49). These findings suggest that elevated plasma s(P)RR concentrations during the first trimester may serve as a predictive biomarker for GDM later in pregnancy.
RF's name
Soluble (Pro) Renin Receptor
Sample's type
Plasma
Gestational weeks
before 14th gestational weeks
Experiemental methods
ELISA
Machine learning algorithms
Logistic Regression
Title
Prediction of gestational diabetes mellitus by soluble (pro)renin receptor during the first trimester
Evidence's type
Risk factor
Year
2013
Journal
Journal of Clinical Endocrinology & Metabolism